Background: Complex parkinsonism is the commonest phenotype in late-onset PLA2G6-associated neurodegeneration.

Objectives: The aim of this study was to deeply characterize phenogenotypically PLA2G6-related parkinsonism in the largest cohort ever reported.

Methods: We report 14 new cases of PLA2G6-related parkinsonism and perform a systematic literature review.

Results: PLA2G6-related parkinsonism shows a fairly distinct phenotype based on 86 cases from 68 pedigrees. Young onset (median age, 23.0 years) with parkinsonism/dystonia, gait/balance, and/or psychiatric/cognitive symptoms were common presenting features. Dystonia occurred in 69.4%, pyramidal signs in 77.2%, myoclonus in 65.2%, and cerebellar signs in 44.6% of cases. Early bladder overactivity was present in 71.9% of cases. Cognitive impairment affected 76.1% of cases and psychiatric features 87.1%, the latter being an isolated presenting feature in 20.1%. Parkinsonism was levodopa responsive but complicated by early, often severe dyskinesias. Five patients benefited from deep brain stimulation. Brain magnetic resonance imaging findings included cerebral (49.3%) and/or cerebellar (43.2%) atrophy, but mineralization was evident in only 28.1%. Presynaptic dopaminergic terminal imaging was abnormal in all where performed. Fifty-four PLA2G6 mutations have hitherto been associated with parkinsonism, including four new variants reported in this article. These are mainly nontruncating, which may explain the phenotypic heterogeneity of childhood- and late-onset PLA2G6-associated neurodegeneration. In five deceased patients, median disease duration was 13.0 years. Brain pathology in three cases showed mixed Lewy and tau pathology.

Conclusions: Biallelic PLA2G6 mutations cause early-onset parkinsonism associated with dystonia, pyramidal and cerebellar signs, myoclonus, and cognitive impairment. Early psychiatric manifestations and bladder overactivity are common. Cerebro/cerebellar atrophy are frequent magnetic resonance imaging features, whereas brain iron deposition is not. Early, severe dyskinesias are a tell-tale sign. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.28807DOI Listing

Publication Analysis

Top Keywords

pla2g6-related parkinsonism
16
parkinsonism
8
late-onset pla2g6-associated
8
cerebellar signs
8
bladder overactivity
8
cognitive impairment
8
early severe
8
severe dyskinesias
8
magnetic resonance
8
resonance imaging
8

Similar Publications

An estimation of global genetic prevalence of PLA2G6-associated neurodegeneration.

Orphanet J Rare Dis

October 2024

Genomenon, Inc, 206 E. Huron St. Suite 114, Ann Arbor, MI, 48109, USA.

Article Synopsis
  • The study focuses on PLA2G6-associated neurodegeneration (PLAN), which includes three diseases with similar symptoms, particularly highlighting infantile neuroaxonal dystrophy (INAD), a condition that affects vision and motor skills from an early age.
  • Researchers estimated the genetic prevalence of PLAN using two approaches: collecting genetic variant data from various databases and analyzing literature to find additional relevant variants. They determined that the estimated prevalence ranges from 1 in 987,267 to 1 in 1,570,079 pregnancies.
  • The findings indicate a significant underdiagnosis of PLAN and suggest a higher presence of PLA2G6 variants in African and Asian populations, emphasizing the need for better diagnostic efforts
View Article and Find Full Text PDF

Phenotype and genotype heterogeneity of PLA2G6-associated neurodegeneration in a cohort of pediatric and adult patients.

Orphanet J Rare Dis

July 2023

Department of Pediatrics, Division of Pediatric Neurology, Children's Medical Center, Pediatrics Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran.

Background: Phospholipase-associated neurodegeneration (PLAN) caused by mutations in the PLA2G6 gene is a rare neurodegenerative disorder that presents with four sub-groups. Infantile neuroaxonal dystrophy (INAD) and PLA2G6-related dystonia-parkinsonism are the main two subtypes. In this cohort, we reviewed clinical, imaging, and genetic features of 25 adult and pediatric patients harboring variants in the PLA2G6.

View Article and Find Full Text PDF
Article Synopsis
  • The growth of molecular genetic testing is speeding up the discovery of new disease-causing genes and expanding the symptoms linked to known genes, particularly in genetic movement disorders.
  • Certain movement disorders are more common in specific ethnic groups, indicating that genetics and clinical presentations can vary across populations.
  • The Movement Disorders in Asia Task Force focuses on genetic movement disorders prevalent in Asia, such as Wilson's disease and various types of ataxias, and considers how specific mutations may present differently in Asian patients compared to global averages.
View Article and Find Full Text PDF

Background: Early onset Parkinson's disease (EOPD) is a neurodegenerative disease associated with the action ofto genetic factors. A mutated phospholipase A2 type VI gene () is considered to be one of pathogenic genes involved in EOPD development. Although EOPD caused by a mutated has been recorded in major databases, not all mutant genotypes have been reported.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!